Advertisement

Human African Trypanosomiasis: The Smoldering Scourge of Africa

  • August StichEmail author
Chapter
  • 2.3k Downloads

Abstract

Human African trypanosomiasis (HAT) or sleeping sickness is one of Africa’s classic tropical diseases. First case reports go back to the fourteenth century. Until recently the impact of HAT on health in Africa has been devastating. Many areas had long been rendered uninhabitable for people and livestock. Millions may have died in Central Africa around Lake Victoria and in the Congo basin within the last 100 years.

Keywords

Visceral Leishmaniasis Human African Trypanosomiasis Trypanosoma Brucei Congo Basin Thick Blood Film 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Brun R, Balmer O (2006) New developments in human African trypanosomiasis. Curr Opin Infect Dis 19:415–420PubMedCrossRefGoogle Scholar
  2. Brun R, Blum J, Chappuis F, Burri C (2009) Human African trypanosomiasis. Lancet. doi:10.1016/S0140-6736(08)61345-8Google Scholar
  3. Burri C, Nkunku S, Merolle A et al (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. The Lancet 355:1419–1425CrossRefGoogle Scholar
  4. Kennedy PGE (2013) Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 12:186–194PubMedCrossRefGoogle Scholar
  5. Jannin J, Cattand P (2004) Treatment and control of human African trypanosomiasis. Curr Opin Infect Dis 17:565–570PubMedCrossRefGoogle Scholar
  6. Pepin J, Milord F, Guern C et al (1989). Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness. Lancet 3:1246–1250CrossRefGoogle Scholar
  7. Priotto G, Kasparian S, Mutombo W et al (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374(9683):56–64PubMedCrossRefGoogle Scholar
  8. Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 5(2):e55PubMedCentralPubMedCrossRefGoogle Scholar
  9. Stich A, Abel PM, Krishna S (2002) Human African Trypanosomiasis. Br Med J 325:203–206CrossRefGoogle Scholar
  10. Stich A, Barrett MP, Krishna S (2003) Waking up to sleeping sickness. Trends Paras 19:195–197CrossRefGoogle Scholar
  11. Yansouni CP, Bottieau E, Lutumba P et al (2013) Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis 13:546–558PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Missionsärztliche KlinikWürzburgGermany

Personalised recommendations